Present Role of Corticosteroids as Antiemetics (Q37199907)

From Wikidata

Revision as of 14:10, 7 July 2024 by ԱշբոտՏՆՂ (talk | contribs) (‎Added [hy] description: գիտական հոդված հրատարակված 1991 թվականի հունվարի 1-ին, based on en:scientific article published on January 1, 1991)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

scientific article published on January 1, 1991

Language	Label	Description	Also known as
English	Present Role of Corticosteroids as Antiemetics	scientific article published on January 1, 1991

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

1 reference

Europe PubMed Central

Present role of corticosteroids as antiemetics (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Present Role of Corticosteroids as Antiemetics (English)

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

author name string

M. S. Aapro

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1857888

11 December 2022

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1857888

11 December 2022

publication date

1 January 1991

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

full work available at URL

http://link.springer.com/content/pdf/10.1007/978-3-642-84138-5_11.pdf

Portable Document Format

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Recent Results in Cancer Research

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

121

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

91-100

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

A randomized multicenter trial of cyclophosphamide, Novantrone and 5-fluorouracil (CNF) versus cyclophosphamide, Adriamycin and 5-fluorouracil (CAF) in patients with metastatic breast cancer

1

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Double-blind crossover study of the antiemetic efficacy of high-dose dexamethasone versus high-dose metoclopramide

2

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Neuropharmacology of Chemotherapy-induced Emesis

3

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

The gastrointestinal tract in chemotherapy-induced emesis. A final common pathway

4

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Advances in anti-emetic therapy

6

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Schweizerische medizinische Wochenschrift

7

111

1614

author name string

R Joss

publication date

1981

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Methodologic issues in trials of antiemetics.

8

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Cancer Treatment Reports

9

70

555

author name string

IN Olver

publication date

1986

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Journal of the National Cancer Institute

10

68

585

author name string

GR Morrow

publication date

1982

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Is cancer treatment toxicity accurately reported?

11

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Early diagnosis of relapse in acute myeloblastic leukemia: Serologic detection of leukemia-associated antigens in human marrow

13

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Methylprednisolone as an antiemetic during cancer chemotherapy--a pilot study

14

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

The New England Journal of Medicine

15

486

304

author name string

BJ Lee

publication date

1981

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

High-dose dexamethasone for prevention of cis-platin-induced vomiting

16

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Behavioral Treatment for the Anticipatory Nausea and Vomiting Induced by Cancer Chemotherapy

17

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

La Presse médicale

18

12

2058

author name string

JL Breau

publication date

1983

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Methylprednisolone as an Antiemetic in Patients on Cis-Platinum Chemotherapy. Results of a Controlled Randomized Study

20

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Randomized open cross-over trial between Metoclopramide (MCP) and dexamethazone (DXM) for the prevention of cisplatin-induced nausea and vomiting

21

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Comparison of methylprednisolone and metoclopramide in the prophylactic treatment of cis-platin-induced nausea and vomiting

22

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Antiemetic efficacy of dexamethasone. Randomized, double-blind, crossover study with prochlorperazine in patients receiving cancer chemotherapy

23

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Dexamethasone vs. placebo for cisplatin-induced emesis. A randomized cross-over trial

24

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Antiemetic efficacy of high-dose dexamethasone versus placebo in patients receiving cisplatin-based chemotherapy: a randomized double-blind controlled clinical trial.

25

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Randomized crossover antiemetic study in cisplatin-treated patients. Comparison between high-dose i.v. metoclopramide and high-dose i.v. dexamethasone

26

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

European Journal of Cancer & Clinical Oncology

27

39

619

author name string

EM Ibrahim

publication date

1986

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Japanese Journal of Cancer and Chemotherapy

29

13

2376

author name string

T Niijima

publication date

1986

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

30

3

333

author name string

S Chiara

publication date

1984

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

The antiemetic efficacy of methylprednisolone compared with metoclopramide in outpatients receiving adjuvant CMF chemotherapy for breast cancer: a randomized trial

31

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Comparison of methylprednisolone and metoclopramide in the prophylactic treatment of cis-platin-induced nausea and vomiting

32

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Methylprednisolone in cis-platinum induced nausea and emesis: a placebo-controlled trial

34

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Comparison of antiemetic efficacy of domperidone, metoclopramide, and dexamethasone in patients receiving outpatient chemotherapy regimens

36

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Double-blind controlled trial of the antiemetic efficacy and toxicity of methylprednisolone (MP), metoclopramide (MTC) and domperidone (DMP) in breast cancer patients treated with i.v. CMF.

37

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Antiemetic efficacy of high-dose dexamethasone: randomized, double-blind, crossover study with a combination of dexamethasone, metoclopramide and diphenhydramine

38

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

A double-blind trial comparing antiemetic efficacy and toxicity of metoclopramide versus methylprednisolone versus domperidone in patients receiving doxorubicin chemotherapy alone or in combination with other antiblastic agents.

39

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Methylprednisolone versus Metoclopramide for Prevention of Nausea and Vomiting in Breast Cancer Patients Treated with Intravenous Cyclophosphamide Methotrexate 5-Fluorouracil: A Double-Blind Randomized Study

40

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Double-blind randomized cross-over trial of dexamethasone and prochlorperazine as anti-emetics for cancer chemotherapy

41

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Effective Control of CMF-Related Emesis with High-Dose Dexamethasone

42

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

High-dose intravenous metoclopramide versus combination high-dose metoclopramide and intravenous dexamethasone in preventing cisplatin-induced nausea and emesis: a single-blind crossover comparison of antiemetic efficacy

43

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Cancer Treatment Reports

46

67

381

author name string

E Bruera

publication date

1986

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Adrenocorticotropic hormone in the prevention of cisplatin-induced nausea and vomiting

47

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Dexamethasone and high dose metoclopramide: efficacy in controlling cisplatin induced nausea and vomiting.

48

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Antiemetic efficacy of high-dose corticosteroids and droperidol in cisplatin-induced emesis: a controlled trial with droperidol and metoclopramide

49

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Cancer Treatment Reports

50

68

1310

author name string

N Panza

publication date

1984

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

The use of methylprednisolone and metoclopramide in control of emesis in patients receiving cis-platinum

51

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Antiemetic efficacy of moderately high-dose metoclopramide in patients receiving varying doses of cisplatin. Controlled comparison with a combination of methylprednisolone and metoclopramide

52

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Improved control of cisplatin-induced emesis with a combination of high doses of methylprednisolone and metoclopramide: a single-blind randomized trial

53

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Japanese Journal of Cancer and Chemotherapy

54

13

2562

author name string

M Fujii

publication date

1986

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Progress in Clinical and Biological Research

55

216

407

author name string

SN Rhinehart

publication date

1986

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

[Prevention of nausea and emesis during cytostatic therapy. Antiemetic efficacy of high-dosage oral metoclopramide without and with prednisone]

56

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Comparison of metoclopramide and metoclopramide plus dexamethasone for complete protection from cisplatinum-induced emesis

58

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Antiemetic activity of high doses of metoclopramide combined with methylprednisolone versus metoclopramide alone in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical Research.

59

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

High doses of methylprednisolone with or without alizapride in the prevention of cisplatin-induced emesis. A randomized, double-blind, crossover study

60

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Methylprednisolone and chlorpromazine in patients receiving cancer chemotherapy: a prospective non-randomized study

62

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

The serotonin type 3 receptor antagonist BRL 43694 and nausea and vomiting induced by cisplatin

64

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

ONDANSETRON WITH AND WITHOUT DEXAMETHASONE TO TREAT CHEMOTHERAPY-INDUCED EMESIS

65

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Japanese Journal of Cancer and Chemotherapy

67

9

1108

author name string

T Ise

publication date

1982

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Methylprednisolone for chemotherapy-induced emesis: a double-blind randomized trial in children

68

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Risk and cost of gastrointestinal side effects associated with nonsteroidal anti-inflammatory drugs

71

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Cancer Treatment Reports

72

63

1327

author name string

M Levitt

publication date

1979

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

The New England Journal of Medicine

73

304

1237

author name string

M Haid

publication date

1981

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Dexamethasone as an antiemetic during cancer chemotherapy

74

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Cancer Treatment Reports

75

67

1013

author name string

MS Aapro

publication date

1983

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

The New England Journal of Medicine

76

314

515

author name string

E Baharav

publication date

1986

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Amelioration of cytotoxic-induced emesis with high-dose metoclopramide, dexamethasone and lorazepam

79

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Cataracts induced by intermittent Decadron used as an antiemetic

80

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

The role of prostaglandins in the excessive nausea and vomiting after intravascular cis-platinum therapy

82

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Acute changes in blood-CSF barrier permselectivity to serum proteins after intrathecal methotrexate and CNS irradiation

83

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Cytotoxic-therapy-induced vomiting is mediated via enkephalin pathways

84

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Methylprednisolone for the control of CMF-induced emesis

86

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

An effective five-drug antiemetic combination for prevention of chemotherapy-related nausea and vomiting. Experience in eighty-four patients

87

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients.

88

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin

89

1 reference

10.1007/978-3-642-84138-5_11

https://api.crossref.org/works/10.1007/978-3-642-84138-5_11

11 December 2022

Identifiers

10.1007/978-3-642-84138-5_11

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37199907&oldid=2197622196"